Management of Mildly Elevated Microalbumin to Creatinine Ratio

Diagnostic Confirmation

• The American Diabetes Association recommends confirming the diagnosis with at least 2 out of 3 abnormal specimens collected within a 3-6 month period due to significant day-to-day variability in urinary albumin excretion 3
• Rule out transient causes of microalbuminuria, including exercise within 24 hours of collection, acute infections or fever, congestive heart failure, marked hyperglycemia, marked hypertension, and urinary tract infections 3, 4

Clinical Significance

• Microalbuminuria is an early marker of kidney damage and a strong predictor of progression to overt nephropathy and end-stage renal disease, as well as increased cardiovascular morbidity and mortality 3, 5

Management Algorithm

Step 1: Optimize Blood Pressure Control

• The American Diabetes Association recommends a target blood pressure of <130/80 mmHg in patients with microalbuminuria 1, 6
• First-line therapy includes ACE inhibitor or ARB, even in normotensive patients, to reduce progression of nephropathy and cardiovascular risk 1, 2

Step 2: Optimize Glycemic Control

• Intensive diabetes management delays onset of microalbuminuria and progression to macroalbuminuria 3
• Target HbA1c <6.5% to reduce risk of progression 1

Step 3: Address Other Risk Factors

• Implement dietary protein restriction to 0.8–1.0 g/kg body weight/day 1
• Consider SGLT2 inhibitors in appropriate patients, particularly those with diabetes 2

Monitoring

• Monitor serum creatinine and potassium levels when using ACE inhibitors, ARBs, or diuretics 1
• Continue monitoring urine albumin-to-creatinine ratio every 6 months to assess treatment response 1, 2
• A reduction in albuminuria of ≥30% is considered a positive response to therapy 2

Referral Considerations

• Consider referral to a nephrologist for uncertainty about etiology of kidney disease, difficult management issues, GFR <30 ml/min/1.73 m², or rapidly progressing kidney disease 1, 6, 7